Literature DB >> 1649179

Mutational analysis of the receptor-activating region of human parathyroid hormone.

T J Gardella1, D Axelrod, D Rubin, H T Keutmann, J T Potts, H M Kronenberg, S R Nussbaum.   

Abstract

The first 4 residues of parathyroid hormone (PTH) are highly conserved in evolution and are important for biological activity. We randomly mutated codons 1-4 of human PTH (hPTH) with degenerate oligonucleotides and, after expression in COS cells, screened the mutants for receptor binding and cAMP-stimulating activity using ROS 17/2.8 cells. This survey identified Glu4 and Val2 as important determinants of receptor binding and activation, respectively. Positions 1 and 3 were more tolerant of substitutions indicating that these sites are less vital to hormone function. Activities of synthetic hPTH(1-34) analogs further demonstrated the importance of positions 2 and 4. The binding affinity of [Ala4,Tyr34] hPTH(1-34)NH2 was 100-fold reduced relative to [Tyr34]hPTH(1-34)NH2 (Kd values = 653 +/- 270 and 4 +/- 1 nM, respectively), and [Arg2, Tyr34]hPTH(1-34)NH2 was a weak partial agonist which bound well to the ROS cell receptor (Kd = 31 +/- 10 nM). The Arg2 analog was nearly as potent as PTH(3-34) as an in vitro PTH antagonist in osteoblast derived cells. However, unlike PTH(3-34), [Arg2]PTH was a full agonist in opossum kidney (OK) cells. These observations suggest that the activation domains of the OK and ROS cell PTH receptors are different. Thus, amino-terminal PTH analogs may be useful as probes for distinguishing properties of PTH receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649179

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Interaction of PTH and PTHrP with their receptors.

Authors:  T J Gardella; H Jüppner
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  The history of parathyroid hormone and its receptor: structure-based design of parathyroid hormone analogues.

Authors:  J T Potts; T J Gardella; H Jüppner; H Kronenberg
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 3.  International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors.

Authors:  Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

4.  The path to the standardization of PTH: Is this a realistic possibility? a position paper of the IFCC C-BM.

Authors:  Etienne Cavalier; Samuel Vasikaran; Harjit P Bhattoa; Annemieke C Heijboer; Konstantinos Makris; Candice Z Ulmer
Journal:  Clin Chim Acta       Date:  2021-01-04       Impact factor: 3.786

Review 5.  In-Cell NMR: Analysis of Protein-Small Molecule Interactions, Metabolic Processes, and Protein Phosphorylation.

Authors:  Amit Kumar; Lars T Kuhn; Jochen Balbach
Journal:  Int J Mol Sci       Date:  2019-01-17       Impact factor: 5.923

6.  Small Molecule Inhibited Parathyroid Hormone Mediated cAMP Response by N-Terminal Peptide Binding.

Authors:  Amit Kumar; Monika Baumann; Jochen Balbach
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.